Building a gene editing lexicon: a model for rare and inherited disorders

by Biotech Newsroom


Rationale for developing a gene editing lexicon in hemophilia

The robust development of a gene editing lexicon for advanced treatments for hemophilia can serve as a template for other therapy areas in the gene therapy space, in which opportunities and barriers for patients are similar. Partnering with patient advocacy groups to support the adoption and dissemination of the lexicon ensures that patients remain the priority. Patient organizations could, in turn, influence how language is used in broader discussions of medical and scientific…



Source link

You may also like

Houston, TX – (EmailWire) — The Biotech Times™ aggregates, publishes and distributes news about the Biotech Industry. In association with EmailWire™, The Biotech Times, helps businesses and organizations in the industry with press release distribution. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us through the following messaging apps:

Free Magazines

Recent Articles

BioTech Times™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC